propidium has been researched along with angiotensin ii in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chiou, WJ; Dickinson, R; Opgenorth, TJ; Wu-Wong, JR | 1 |
| Kong, JY; Rabkin, SW | 1 |
2 other study(ies) available for propidium and angiotensin ii
| Article | Year |
|---|---|
Endothelin attenuates apoptosis in human smooth muscle cells.
Topics: Angiotensin II; Annexin A5; Apoptosis; Atrasentan; Cell Survival; DNA Fragmentation; Endothelin Receptor Antagonists; Endothelin-1; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Humans; Male; Muscle, Smooth; Paclitaxel; Pericardium; Phosphatidylserines; Propidium; Prostate; Pyrrolidines | 1997 |
Angiotensin II does not induce apoptosis but rather prevents apoptosis in cardiomyocytes.
Topics: Angiotensin II; Animals; Animals, Newborn; Apoptosis; Camptothecin; Cell Nucleus; Cell Separation; Cells, Cultured; Chick Embryo; Culture Media, Serum-Free; DNA Fragmentation; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Heart; In Situ Nick-End Labeling; Mice; Myocardium; Necrosis; Propidium; Staurosporine; Tetrazolium Salts; Thiazoles; Time Factors | 2000 |